OraSure Technologies Stock Forecast for 2023 - 2025 - 2030
Updated on 04/30/2024
OraSure Technologies Stock Forecast and Price Target
If OraSure Technologies's stock price reached the average yearlong target of $7.25 given by four well-known analysts in recent months, there would be a potential upside of approximately 34.26% from its last closing price in April, 2024. This potential increase is based on a high estimate of $9.00 and a low estimate of $6.50. If interested in OSUR stock, you may also want to consider its competitors.
34.26% Upside
OraSure Technologies Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, OraSure Technologies's Price has grown, increasing from $0.00 to $0.00 – an increase of 100.00%. For next year, the 3 analysts predict Fair Value of $5.80, which would mean an increase of 100.00%. Over the next eight years, the pros' prediction is Fair Valueof $10.97, which would mean a eight-year growth forecast of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$146.82 | Buy/Sell | $174.55 | 15.79% |
| TMO Stock Forecast | Thermo Fisher Scientific | Outperform |
10
|
$576.89 | Buy/Sell | $591.94 | 6.61% |
| ROG Stock Forecast | Roche Holding | Hold |
16
|
CHF221.20 | Buy/Sell | CHF307.83 | 23.19% |
| ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$107.27 | Buy/Sell | $118.92 | 17.93% |
| SIE Stock Forecast | Siemens | Outperform |
10
|
177.64€ | Buy/Sell | 178.14€ | 10.05% |
OraSure Technologies Revenue Forecast for 2023 - 2025 - 2030
In the last three years, OraSure Technologies's Revenue has grown, increasing from $171.65M to $405.47M – an increase of 136.22%. According to 6 major analysts, OraSure Technologies's Revenue will fall by 51.44% in the next year, reaching $196.90M. Professionals believe that By 2030, OraSure Technologies's Revenue will fall to $260.40M– a 35.78% decrease from its current value.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IDXX Stock Forecast | IDEXX Laboratories | Outperform |
14
|
$505.34 | Buy/Sell | $583.92 | 18.73% |
| CHD Stock Forecast | Church & Dwight Co Inc | Hold |
11
|
$106.91 | Buy/Sell | $96.90 | -1.13% |
| LH Stock Forecast | Laboratory Corp of America Hol... | Outperform |
11
|
$204.17 | Buy/Sell | $241.28 | 18.04% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| DGX Stock Forecast | Quest Diagnostics | Outperform |
10
|
$139.50 | Buy/Sell | $141.17 | 3.94% |
| TECH Stock Forecast | Bio-Techne Corp | Buy |
16
|
$64.51 | Buy/Sell | $100.78 | 24.01% |
| BIO Stock Forecast | Bio-Rad Laboratories Inc | Buy |
16
|
$277.11 | Buy/Sell | $536.80 | 53.98% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 4042 Stock Forecast | Tosoh | Outperform |
18
|
¥2.05k | Buy/Sell | ¥2.19k | 0.05% |
| NEOG Stock Forecast | Neogen | Outperform |
16
|
$12.42 | Buy/Sell | $37.00 | 36.88% |
| MYGN Stock Forecast | Myriad Genetics | Hold |
6
|
$19.80 | Buy/Sell | $22.08 | 26.26% |
OraSure Technologies EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, OraSure Technologies's EBITDA has grown by 1738.57%, from $3.50M to $64.35M. In the following year, 1 experts forecast that OraSure Technologies's EBITDA will decrease by 112.74%, to $-8.20M. Over the next seven years, experts predict that EBITDA will grow by 15.62%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NYMX.F Stock Forecast | Nymox Pharmaceutical | - |
9
|
$0.47 | Buy/Sell | $0.00 | -100.00% |
| MIR Stock Forecast | MedMira | - |
0
|
C$0.11 | Buy/Sell | C$0.20 | -100.00% |
| BMRA Stock Forecast | Biomerica | - |
4
|
$0.91 | Buy/Sell | $13.00 | -100.00% |
OraSure Technologies EBIT Forecast for 2023 - 2025 - 2030
In the last three years, OraSure Technologies's EBIT has grown from $-5.88M to $43.41M – a 838.27% increase. 4 analysts predict OraSure Technologies's EBIT will decrease by 152.48% in the next year, reaching $-22.78M. By 2030, professionals predict that OraSure Technologies's EBIT will decrease by 232.62%, to $-57.57M.
OraSure Technologies EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, OraSure Technologies's EPS has grown, increasing from $-0.24 to $0.00 – an increase of 100.00%. For next year, the 3 analysts predict EPS of $-0.37, which would mean an increase of 100.00%. Over the next eight years, the pros' prediction is EPSof $-0.30, which would mean a eight-year growth forecast of 100.00%.
.jpg)